Dr. Riess seeks to deliver exceptional clinical care by leveraging advances at UC Davis in novel diagnostics, targeted therapies and immunotherapy, while providing effective symptom management with a holistic approach towards patient care. Dr. Riess believes in high quality, innovative, and compassionate care of his patients. Dr. Riess believes in a team-based approach to patient care, utilizing expertise of nurses, pharmacists, social workers, and consultants to provide complete care for his patients.
Dr. Riess is Medical Director of Thoracic Oncology. Dr. Riess' clinical interests include lung cancer and other thoracic cancers (mesothelioma and thymoma) as well as head and neck cancers. He currently serves on the Non-Small Cell Lung Cancer/Malignant Pleural Mesothelioma/Thymomas and Thymic Carcinomas Panel for the National Comprehensive Cancer Network (NCCN). Dr. Riess seeks to deliver exceptional clinical care by leveraging advances at UC Davis in novel diagnostics, targeted therapies and immunotherapy, while providing effective symptom management with a holistic approach towards patient care.
Dr. Riess' research interests encompass novel diagnostics, targeted therapies and immunotherapies in lung cancer and other thoracic malignancies. He is the past recipient of the National Cancer Institute Cancer Clinical Investigator Team Leadership Award given to researchers who are working to improve the lives of people with cancer through extensive involvement in NCI-funded collaborative clinical trials and whose leadership, participation and activities promote clinical trials and research. He is also the past (co)recipient of the Addario Lung Cancer Foundation and Van Auken Foundation Young Innovators Team Award.